Cellebrite
CLBT
48 hedge funds and large institutions have $294M invested in Cellebrite in 2021 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 5 closing their positions.
420% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 5
412% more call options, than puts
Call options by funds: $2.06M | Put options by funds: $403K
78% more funds holding
Funds holding: 27 → 48 (+21)
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
57% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 7
46% more capital invested
Capital invested by funds: $201M → $294M (+$92.8M)
7.95% more ownership
Funds ownership: 11.61% → 19.56% (+7.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GRIM
Greenhaven Road Investment Management
Greenwich,
Connecticut
|
+$11.1M |
| 2 |
BCM
Bienville Capital Management
New York
|
+$9.01M |
| 3 |
MCM
Makena Capital Management
Menlo Park,
California
|
+$6.12M |
| 4 |
PF
Phoenix Financial
Givatayim,
Israel
|
+$5.36M |
| 5 |
GIP
General Industrial Partners
London,
United Kingdom
|
+$5.03M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$25M |
| 2 |
IP
Isomer Partners
New York
|
-$6.69M |
| 3 |
CC
Crosslink Capital
Menlo Park,
California
|
-$1.77M |
| 4 |
CPM
Crescent Park Management
East Palo Alto,
California
|
-$1.06M |
| 5 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$444K |
CLBT Hedge Fund Activity: Q4 2021 in Review
48 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Cellebrite (CLBT) for Q4 2021, worth a combined $294M — up 46% from $201M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new CLBT positions and 5 closed out — a net gain of 21 holders — while 11 added to existing stakes and 7 trimmed.
The largest buyer was Greenhaven Road Investment Management, opening a new position worth an estimated $11.1M. The largest seller was Park West Asset Management, exiting entirely with an estimated $25M sold.
- 48 institutional investors held Cellebrite (CLBT) as of Q4 2021, up from 27 in Q3 2021.
- Funds reported $294M of Cellebrite stock for Q4 2021, up 46% quarter-over-quarter.
- 26 funds opened new Cellebrite positions in Q4 2021 and 5 closed out, a net change of +21 holders.
- The largest Cellebrite buyer in Q4 2021 was Greenhaven Road Investment Management, an estimated $11.1M added.
- The largest Cellebrite seller in Q4 2021 was Park West Asset Management, an estimated $25M sold.
Based on aggregated 13F filings for Q4 2021.